These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 15582940

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma.
    Hohlfeld JM, Schmiedl A, Erpenbeck VJ, Venge P, Krug N.
    J Allergy Clin Immunol; 2004 Mar; 113(3):496-502. PubMed ID: 15007353
    [Abstract] [Full Text] [Related]

  • 3. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W, Grube C, Günther A, Schmidt R.
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [Abstract] [Full Text] [Related]

  • 4. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran.
    Ochs M, Schüttler M, Stichtenoth G, Herting E.
    Respir Res; 2006 Jun 06; 7(1):86. PubMed ID: 16756655
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A, Linderholm B, Haegerstrand-Björkman M, Curstedt T.
    Pediatr Res; 2012 Sep 06; 72(3):262-9. PubMed ID: 22691953
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.
    Park J, Bae CW, Choi YM.
    J Korean Med Sci; 1998 Apr 06; 13(2):123-30. PubMed ID: 9610611
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Resistance of different surfactant preparations to inactivation by meconium.
    Herting E, Rauprich P, Stichtenoth G, Walter G, Johansson J, Robertson B.
    Pediatr Res; 2001 Jul 06; 50(1):44-9. PubMed ID: 11420417
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic surfactants modulate the viability of eosinophils and induce inflammatory mediator release.
    Erpenbeck VJ, Fischer I, Wiese K, Schaumann F, Schmiedl A, Nassenstein C, Krug N, Hohlfeld JM.
    Int Arch Allergy Immunol; 2009 Jul 06; 149(4):333-42. PubMed ID: 19295237
    [Abstract] [Full Text] [Related]

  • 16. Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery.
    Baldassi D, Ngo TMH, Merkel OM.
    Pharm Res; 2024 Jan 06; 41(1):77-91. PubMed ID: 36447020
    [Abstract] [Full Text] [Related]

  • 17. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant.
    Ernst N, Ulrichskötter S, Schmalix WA, Rädler J, Galneder R, Mayer E, Gersting S, Plank C, Reinhardt D, Rosenecker J.
    J Gene Med; 1999 Jan 06; 1(5):331-40. PubMed ID: 10738550
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.